Home

JOEL S MARCUS

CIK 1216955 · Executive Chairman · last filed 2026-05-07

JOEL S MARCUS is an Executive Chairman who has filed 287 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing shows the insider bought $347.6K of ARE on May 7, 2026. Across all open-market trades the lifetime net is −$156.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $54.9M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$54.94M

Companies

8

Total Filings

287

Lifetime Open-Market Net

-$156.07M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ARE Executive Chairman 587,724 $48.35 $28.42M -$139.75M 193 2026-05-07
Intra-Cellular Therapies, Inc. (ITCI) Delisted Director 0 $131.87 $0 -$13.07M 43 2025-04-02
Applied Therapeutics, Inc. (APLT) Delisted Director 565,849 $0.10 $58.3K -$257.6K 15 2024-06-07
Korro Bio, Inc. (FREQ) Delisted Director 26,377 $14.98 $395.1K -$1.32M 11 2022-08-19
MGTX Director 1,995,608 $13.02 $25.98M -$294.2K 7 2022-06-09
ATRA Director 460 $8.61 $4.0K -$1.52M 12 2019-03-19
REXR Director 12,858 $36.47 $468.9K $140.0K 1 2013-07-24
PMT Director 7,000 $9.38 $65.7K $0 2 2012-05-18

Recent Filings

287 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-05-07 ARE Buy (P) +7,500 $347.6K EDGAR
2026-05-06 ARE Buy (P) +7,500 $320.4K EDGAR
2026-05-05 ARE Buy (P) +10,000 $410.2K EDGAR
2026-02-13 ARE Buy (P) +25,000 $1.35M EDGAR
2026-01-26 ARE Disp (D) −49,746 $0 EDGAR
2026-01-13 ARE Grant (A) +100,056 $0 EDGAR
2026-01-05 ARE Grant (A) +31,270 $0 EDGAR
2025-04-02 Intra-Cellular Therapies, Inc. (ITCI) Delisted Disp (D) −58,238 -$7.69M EDGAR
2025-02-26 Intra-Cellular Therapies, Inc. (ITCI) Delisted Exer (M) +7,009 $447.1K EDGAR
2025-01-14 ARE Grant (A) +46,207 $0 EDGAR
Showing 1–10 of 287
Page 1 of 29
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.